Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies
Cannabis Law Report
JUNE 16, 2021
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.
Let's personalize your content